SCHEMBL17907958

SCHEMBL17907958

Cc1ccc2[nH]c(C=CC(=O)O)cc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.55
DAO P14920 1/20 0.47
FLT3 P36888 4/20 0.47
PDGFRB P09619 1/20 0.47
PDGFRA P16234 1/20 0.47
TP53 P04637 1/20 0.46
POLB P06746 1/20 0.46
RAB9A P51151 3/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HSD17B10 Q99714 2/20 0.46
HPGD P15428 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
NPC1 O15118 2/20 0.43
CYP26A1 O43174 2/20 0.43
CYP26B1 Q9NR63 2/20 0.43
HRH4 Q9H3N8 1/20 0.42
LOXL2 Q9Y4K0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17907955 1.00 PIN1 (0.55) PIN1DAOFLT3PDGFRBPDGFRA
SCHEMBL5829213 0.82 PDGFRB (0.57) FLT3PDGFRBPDGFRAPOLBRAB9A
SCHEMBL5829214 0.82 PDGFRB (0.57) FLT3PDGFRBPDGFRAPOLBRAB9A
SCHEMBL17908002 0.81 F7 (0.55) DAOFLT3RAB9AKDM4EALDH1A1
SCHEMBL17907980 0.81 KDM4E (0.55) DAOFLT3KDM4EALDH1A1HSD17B10
SCHEMBL17908005 0.81 F7 (0.55) DAOFLT3RAB9AKDM4EALDH1A1
SCHEMBL17907978 0.81 KDM4E (0.55) DAOFLT3KDM4EALDH1A1HSD17B10
SCHEMBL30640889 0.79 CYP2A6 (0.58) DAOFLT3RAB9AKDM4EHSD17B10
SCHEMBL29455098 0.79 CYP2A6 (0.58) DAOFLT3RAB9AKDM4EHSD17B10
SCHEMBL245110 0.79 CYP2A6 (0.58) DAOFLT3RAB9AKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2697223-B1 7-(HETEROARYL-AMINO)-6,7,8,9-TETRAHYDROPYRIDO[1,2-A]INDOL ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2016-07-13 EP disclosed